Adimab Provides 2018 Update on Clinical Pipeline

Adimab, LLC, the global leader in the discovery and optimization of fully human monoclonal and bispecific antibodies, today announced that 12 new partner programs entered clinical development in 2018. This brings the total number of [...]

FierceBiotech Names Compass Therapeutics a 2018 “Fierce 15” Biotech Company

Compass Therapeutics, a biotechnology company committed to the ambitious goal of comprehensively drugging the human immune system, today announced that it has been named by FierceBiotech as one of 2018’s Fierce 15 biotechnology companies, designating [...]

Vets First Choice Wins Approval to Build New Headquarters in Downtown Portland

Vets First Choice has received city approval to commence construction of a new headquarters in Portland, Maine to support its rapid growth and expansion. The new approximately 170,000 square foot facility will support more than [...]

Evox Therapeutics completes £35 million Series B financing

Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, today announces that it has raised £35.5 million ($45.4 million) of new capital in a Series B financing round. Redmile Group led the [...]

Jesse Devitte

Contact Us

We’re always interested in engaging with inventors, creators, and entrepreneurs to help develop ideas and realize visions.

icon-phone 603.643.1500

icon-mail investors@borealisventures.com